Trial intelligence / Profile preview

Dronabinol for Fear Extinction Memory

NCT02472847Phase 4Completed

Sponsor
University of Illinois Chicago
Start
May 2012
Primary completion
Jul 2014
Modality
Small Molecules
01

Overview

A Phase 4 trial of dronabinol in post-traumatic stress disorder (PTSD), anxiety disorders, sponsored by University of Illinois Chicago. Started May 2012; status: completed.

02

Drugs

dronabinol
03

Conditions

post-traumatic stress disorder (PTSD)anxiety disorders

Beyond the preview

Go deeper on NCT02472847.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02472847.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call